Next Article in Journal / Special Issue
Molecular Therapeutic Advances in Personalized Therapy of Melanoma and Non-Small Cell Lung Cancer
Previous Article in Journal / Special Issue
Personalized Medicine and Cancer
Article Menu

Export Article

Open AccessOpinion
J. Pers. Med. 2012, 2(1), 15-34; doi:10.3390/jpm2010015

Trends in Personalized Therapies in Oncology: The (Venture) Capitalist’s Perspective

Index Ventures, Rue de Jargonnant 2, 1207 Geneva, Switzerland
*
Author to whom correspondence should be addressed.
Received: 9 February 2012 / Revised: 22 February 2012 / Accepted: 29 February 2012 / Published: 7 March 2012
(This article belongs to the Special Issue Recent Advances in Personalized Medicine)
View Full-Text   |   Download PDF [323 KB, uploaded 7 March 2012]   |  

Abstract

Oncology is one of the most important fields of personalized medicine as a majority of efforts in this field have recently centered on targeted cancer drug development. New tools are continuously being developed that promise to make cancer treatment more efficacious while causing fewer side effects. Like most industries, the biopharmaceutical industry is also following certain global trends and these are analyzed in this article. As academia and industry are mutually dependent on each other, researchers in the field should be aware of those trends and the immediate consequences for their research. It is important for the future of this field that there is a healthy relationship among all interested parties as the challenges of personalized medicine are becoming ever more complex. View Full-Text
Keywords: global industry trends; collaboration BioPharma–Academia; oncology drug development; translational research global industry trends; collaboration BioPharma–Academia; oncology drug development; translational research
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Fleck, R.; Bach, D. Trends in Personalized Therapies in Oncology: The (Venture) Capitalist’s Perspective. J. Pers. Med. 2012, 2, 15-34.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
J. Pers. Med. EISSN 2075-4426 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top